HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Wheeler Selected Research

azelastine (Optivar)

7/2011Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
8/2010Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
1/2010Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
11/2009Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
9/2009Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
1/2008Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
9/2007Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Wheeler Research Topics

Disease

11Neoplasms (Cancer)
10/2021 - 01/2009
7Seasonal Allergic Rhinitis (Hay Fever)
07/2011 - 09/2007
6Lung Neoplasms (Lung Cancer)
01/2017 - 01/2009
3Carcinogenesis
10/2021 - 03/2014
3Adenocarcinoma
10/2021 - 08/2015
3Cardiovascular Diseases (Cardiovascular Disease)
12/2016 - 12/2011
3Urinary Bladder Neoplasms (Bladder Cancer)
10/2014 - 11/2010
3Tobacco Use Disorder (Nicotine Dependence)
12/2013 - 01/2009
2Breast Neoplasms (Breast Cancer)
10/2021 - 06/2019
2Genetic Predisposition to Disease (Genetic Predisposition)
10/2021 - 07/2014
2Prostatic Neoplasms (Prostate Cancer)
11/2017 - 05/2011
2Osteoporosis
06/2014 - 07/2010
2Sleepiness
07/2011 - 11/2009
1Iron Overload
10/2021
1Hemochromatosis (Bronze Diabetes)
10/2021
1Lung Injury
02/2020
1Mason-Type Diabetes
06/2019
1Cardiomegaly (Heart Hypertrophy)
06/2019
1Empyema
01/2018
1Adenocarcinoma of Lung
01/2017
1Type 2 Diabetes Mellitus (MODY)
12/2016
1Carcinoma (Carcinomatosis)
01/2016
1Hepatocellular Carcinoma (Hepatoma)
01/2016
1Vascular Diseases (Vascular Disease)
05/2015
1Arthritis (Polyarthritis)
06/2014
1Esophageal Squamous Cell Carcinoma
05/2013
1Cutaneous Malignant Melanoma
01/2013
1Inflammation (Inflammations)
01/2013
1Chromosome Aberrations (Chromosome Abnormalities)
05/2012
1Leukemia
05/2012
1Thyroid Neoplasms (Thyroid Cancer)
02/2012
1Papillary Thyroid Cancer
02/2012
1Herpes Simplex
01/2012
1Asthma (Bronchial Asthma)
12/2011
1Communicable Diseases (Infectious Diseases)
12/2011
1Hypersensitivity (Allergy)
07/2011
1Multiple Sclerosis
07/2010
1Rickets (Rachitis)
07/2010
1Allergic Rhinitis
11/2009
1Back Pain (Backache)
02/2008
1Spasm (Spasms)
02/2008
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2008
1Infections
01/2008
1Perennial Allergic Rhinitis
09/2007

Drug/Important Bio-Agent (IBA)

7Nasal SpraysIBA
07/2011 - 09/2007
7azelastine (Optivar)FDA LinkGeneric
07/2011 - 09/2007
4Biological ProductsIBA
05/2015 - 05/2012
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2013 - 01/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2012
3Genetic Markers (Genetic Marker)IBA
10/2014 - 01/2009
2P-2 (P 2)IBA
12/2016 - 11/2010
2Vitamin DFDA LinkGeneric
06/2014 - 07/2010
2Gonadal Steroid Hormones (Sex Hormones)IBA
05/2013 - 02/2012
2beta Carotene (Betacarotene)FDA Link
05/2012 - 12/2011
2alpha-TocopherolFDA Link
05/2012 - 12/2011
2Fluticasone (Cutivate)FDA LinkGeneric
08/2010 - 01/2008
15- ((5- methyl- 3- thienyl)oxy)- 2(1H)- pyrimidinoneIBA
10/2021
1IronIBA
10/2021
1HepcidinsIBA
10/2021
1Cardiotonic Agents (Cardiac Stimulants)IBA
02/2020
1ErbB Receptors (EGF Receptor)IBA
06/2019
1Epidermal Growth Factor (EGF)IBA
06/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2019
1Biomarkers (Surrogate Marker)IBA
10/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1MelatoninIBA
11/2017
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2017
1LipidsIBA
12/2016
1Triglycerides (Triacylglycerol)IBA
12/2016
1Insulin (Novolin)FDA Link
01/2016
1ChromatinIBA
08/2015
1MicroRNAs (MicroRNA)IBA
08/2015
1Proteins (Proteins, Gene)FDA Link
10/2014
1Cyclin EIBA
10/2014
1CotinineIBA
12/2013
1Protein C InhibitorIBA
01/2013
1CholesterolIBA
05/2012
1Tocopherols (Tocopherol)IBA
05/2012
1Hormones (Hormone)IBA
02/2012
1Estrogen ReceptorsIBA
02/2012
1Estrogens (Estrogen)FDA Link
02/2012
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2012
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2012
1Vitamin A (Retinol)FDA LinkGeneric
12/2011
1Transcription Factors (Transcription Factor)IBA
05/2011
1Peptide Hydrolases (Proteases)FDA Link
05/2011
1Cholinergic Agents (Cholinergics)IBA
08/2010
1hydroxide ionIBA
07/2010
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
11/2009
1TabletsIBA
02/2008
1Carisoprodol (Soma)FDA LinkGeneric
02/2008
1Pharmaceutical PreparationsIBA
02/2008
1EnzymesIBA
01/2008

Therapy/Procedure

2Therapeutics
08/2010 - 01/2008
1Artificial Respiration (Mechanical Ventilation)
02/2020
1Critical Care (Surgical Intensive Care)
02/2020